Cell-free Assays (IC50/Ki) for Brigimadlin
| Key Target | IC50 (Cell-free) | Description | Reference |
|---|---|---|---|
| No published data available. | |||
Cell-based Assay (IC50) for Brigimadlin
| Cell Type | IC50 (Cell-based) | Description | Reference |
|---|---|---|---|
| SJSA-1 | 12 nmol/L | proliferation assay | PMC10401071 |
| TP53 wild-type GBM (GBM46, GBM108, GBM143, GBM148, GBM8, GBM10, GBM14) | 0.8-6.6 nmol/L | Cell Titer-Glo 3D assay | PMC12883205 |
Check the
Brigimadlin
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Jump to
- Brigimadlin Mechanism of Action: MDM2 Inhibition in Tumor Cell Research
- Brigimadlin Clinical Trials
- Brigimadlin Working Concentration | Cell Culture | Treatment
- Brigimadlin Solubility in DMSO
- Brigimadlin Stock Solution
- Brigimadlin Storage
- Brigimadlin Stability
- Brigimadlin Molecular Weight
- Brigimadlin CAS Number
- Brigimadlin Chemical Structure (2D and 3D)
- Brigimadlin Sigma (BL3H9A9A3569)? Try a better option.
- Brigimadlin MedChemExpress (HY-152859)? Try a better option.
- Brigimadlin Cayman (44353)? Try a better option.
- Brigimadlin APExBIO (BA3461)? Try a better option.
- Brigimadlin SDS｜MSDS